Ever since Type A personality was linked to cardiovascular disease in the 1950s, it’s been known that anger raises the risk of heart attack and stroke. Now a Columbia study may explain how.
Extended-release naltrexone initiated after just five to seven days of seeking treatment is more effective than starting treatment after the traditional interim stage of 10 to 15 days.
Columbia neuroscientists found that the mouse brain can direct the body's immune system to an unexpected degree, a discovery that could lead to new therapies for many immune disorders.
A new study reveals how bone marrow stem cell niche generation is regulated, which could lead to improvements in stem cell transplantation for the treatment of blood diseases.
The genetic changes that made it possible for humans to walk upright have been uncovered in a study that also shows how slight variations in skeletal proportions are linked to arthritis.
Columbia researchers have found why babies are susceptible to repeated bouts of common respiratory infections—but also have a unique weapon to fight off new pathogens that healthy adults lack.
A new study in mice, led by Columbia University researchers, suggests experimental eye drops may be more effective than injections for treatment of retinal vein occlusion, a major cause of blindness.
Each year, several medical students work for 12 months as dean’s research fellows. An increase in applications shows more students are interested in learning the fundamental tools of research.